Erlocip 100mg Tablet

Erlocip 100mg Tablet contains Erlotinib, a selective oral tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR). This medication is primarily prescribed for patients with advanced non-small cell lung cancer (NSCLC) and pancreatic cancer. By blocking EGFR signaling, Erlotinib disrupts cancer cell proliferation, making it a vital component of modern cancer therapy.

Key Features:

• Contains Erlotinib, an effective oral targeted therapy
• Indicated for non-small cell lung cancer (NSCLC) and pancreatic cancer
• Inhibits the activity of EGFR to slow down tumor growth
• Convenient oral dosage form for improved patient adherence
• Often used in combination with other cancer treatment modalities